Safi Dokmak

Safi Dokmak

Auto-generated profile, based on publicly available information

Safi Dokmak

Department of HPB Surgery and Liver Transplantation, DMU DIGEST, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris, Clichy, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
SDSafi Dokmak
Safi Dokmak
FFFadhel Samir Ftériche
Fadhel Samir Ftériche
BABéatrice Aussilhou
Béatrice Aussilhou
YBYacine Bensafta
Yacine Bensafta
PLPhilippe Lévy
Philippe Lévy
SASauvanet Alain
Sauvanet Alain
Laparoscopic pancreaticoduodenectomy (LPD) is a difficult procedure that has become increasingly popular. Nevertheless, comparative data on outcomes remain limited. Our aim was to compare the outcomes of LPD and open pancreaticoduodenectomy (OPD). Between April 2011 and April 2014, 46 LPD were performed and compared with 46 OPD, which theoretically can be done by the laparoscopic approach. Patients were also matched for demographic data, associated comorbidities, and underlying disease. Patient demographics and perioperative and postoperative outcomes were studied from our single center prospective database. Lower BMI (23 vs 27 kg/m(2), p < 0.001) and a soft pancreas (57% vs 47%, p = 0.38) were observed in patients with LPD, but there were no differences in associated comorbidities or underlying disease. Surgery lasted longer in the LPD group (342 vs 264 minutes, p < 0.001). One death occurred in the LPD group (2.1% vs 0%, p = 0.28) and severe morbidity was higher (28% vs 20%, p = 0.32) in LPD due to grade C pancreatic fistula (PF) (24% vs 6%, p = 0.007), bleeding (24% vs 7%, p = 0.02), and revision surgery (24% vs 11%, p = 0.09). Pathologic examination for malignant diseases did not identify any differences between the LPD and OPD as far as size (2.51 vs 2.82 cm, p = 0.27), number of harvested (20 vs 23, p = 0.62) or invaded (2.4 vs 2, p = 0.22) lymph nodes, or R0 resection (80% vs 80%; p = 1). Hospital stays were similar (25 vs 23 days, p = 0.59). There was no difference in outcomes between approaches in patients at a lower risk of PF. This study found that LPD is associated with higher morbidity, mainly due to more severe PF. Laparoscopic pancreaticoduodenectomy should be considered only in the subgroup of patients with a low risk of PF.

1 August 2015 in Annals of Surgery
Verified
Journal Article
Closed access
SDSafi Dokmak
Safi Dokmak
BABéatrice Aussilhou
Béatrice Aussilhou
SASauvanet Alain
Sauvanet Alain
GNGanesh Nagarajan
Ganesh Nagarajan
OFOlivier Farges
Olivier Farges
JBJacques Belghiti
Jacques Belghiti
Objective: To evaluate the parietal peritoneum (PP) as an autologous substitute for venous reconstruction during hepatopancreatobiliary (HPB) surgery. Background: Venous resection during liver or pancreatic resection may require a rapidly available substitute especially when the need for venous resection is unforeseen. Methods: The PP was used as an autologous substitute during complex liver and pancreatic resections. Postoperative anticoagulation was standard and venous patency was assessed by routine computed tomographic scans. Results: Thirty patients underwent vascular resection during pancreatic (n = 18) or liver (n = 12) resection, mainly for malignant tumors (n = 29). Venous resection was an emergency procedure in 4 patients due to prolonged vascular occlusion. The PP, with a mean length of 22 mm (15–70), was quickly harvested and used as a lateral (n = 28) or a tubular (n = 2) substitute for reconstruction of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3). Severe morbidity included Clavien grade-III complications in 4 (13%) patients but there was no PP-related or hemorrhagic complications. Histological vascular invasion was present in 18 (62%) patients, and all had an R0 resection (100%). After a mean follow-up of 14 (7–33) months, all venous reconstructions were patent except for 1 tubular graft (97%). Conclusions: A PP can be safely used as a lateral patch for venous reconstruction during HPB surgery; this could help reduce reluctance to perform vascular resection when oncologically required. Clinical trials identification: NCT02121886.

29 April 2021 in Blood
Verified
Journal Article
Open access
PDF file
CRCamille Roussel
Camille Roussel
AMAlexandre Morel
Alexandre Morel
MDMichaël Dussiot
Michaël Dussiot
MMMickael MARIN
Mickael MARIN
MCMartin Colard
Martin Colard
PAPascal Amireault
Pascal Amireault
Permanent availability of red blood cells (RBCs) for transfusion depends on refrigerated storage, during which morphologically altered RBCs accumulate. Among these, a subpopulation of small RBCs, comprising type III echinocytes, spheroechinocytes, and spherocytes and defined as storage-induced microerythrocytes (SMEs), could be rapidly cleared from circulation posttransfusion. We quantified the proportion of SMEs in RBC concentrates from healthy human volunteers and assessed correlation with transfusion recovery, investigated the fate of SMEs upon perfusion through human spleen ex vivo, and explored where and how SMEs are cleared in a mouse model of blood storage and transfusion. In healthy human volunteers, high proportion of SMEs in long-stored RBC concentrates correlated with poor transfusion recovery. When perfused through human spleen, 15% and 61% of long-stored RBCs and SMEs were cleared in 70 minutes, respectively. High initial proportion of SMEs also correlated with high retention of RBCs by perfused human spleen. In the mouse model, SMEs accumulated during storage. Transfusion of long-stored RBCs resulted in reduced posttransfusion recovery, mostly due to SME clearance. After transfusion in mice, long-stored RBCs accumulated predominantly in spleen and were ingested mainly by splenic and hepatic macrophages. In macrophage-depleted mice, splenic accumulation and SME clearance were delayed, and transfusion recovery was improved. In healthy hosts, SMEs were cleared predominantly by macrophages in spleen and liver. When this well-demarcated subpopulation of altered RBCs was abundant in RBC concentrates, transfusion recovery was diminished. SME quantification has the potential to improve blood product quality assessment. This trial was registered at www.clinicaltrials.gov as #NCT02889133.

1 August 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
SDSafi Dokmak
Safi Dokmak
FFFadhel Samir Ftériche
Fadhel Samir Ftériche
BABéatrice Aussilhou
Béatrice Aussilhou
PLPhilippe Lévy
Philippe Lévy
PRPhilippe Ruszniewski
Philippe Ruszniewski
SASauvanet Alain
Sauvanet Alain
Although laparoscopic pancreatic resection (LPR) has become routine, large single-center series are still lacking. Our aim was to analyze the results of a large European single-center series of LPR. Between January 2008 and September 2015, 300 LPRs were performed and studied prospectively, including 165 (55%) distal pancreatectomies, 68 (23%) pancreaticoduodenectomies (PDs), 30 (10%) enucleations, 35 (11%) central pancreatectomies, and 2 (1%) total pancreatectomies. Mean age was 54 ± 15.4 years old (range 17 to 87 years), and most patients were women (58%). Laparoscopic pancreatic resection was performed for malignancy (46%), low potential malignant (44%), or benign (10%) diseases. The mean operative durations were 211 ± 102 minutes (range 30 to 540 minutes) for the entire population and 351 ± 59 minutes (range 240 to 540 minutes) for PD, and decreased with the learning curve. Mean blood loss was 229 ± 269 mL (range 0 to 1,500 mL), and 13 patients (4%) received transfusions. Conversion to an open procedure was required in 12 patients (4%), and only 5 in the last 250 patients (14% vs 2%; p < 0.001). Mortality occurred in 4 (1.3%) patients and only after PD (5.8%). Common complications were pancreatic fistula (n = 124, 41%), bleeding (n = 35, 12%), and reoperation (n = 28, 9%). The postoperative outcomes were less favorable in procedures with a reconstruction phase (n = 105) than in those without (n = 195), with increased mortality (3.8% vs 0%; p = 0.04), overall morbidity (76% vs % 52%; p < 0.001), and mean hospital stay (26 ± 15 days vs 16 ± 10 days; p < 0.001). Laparoscopic pancreatic resection without a reconstruction phase has excellent outcomes; LPR with a reconstruction phase, especially PD, has less favorable outcomes, and further randomized studies are required to draw conclusions on the safety and benefits of this approach.

1 February 2014 in HPB
Verified
Journal Article
Open access
PDF file
SDSafi Dokmak
Safi Dokmak
VRVikram Raut
Vikram Raut
BABéatrice Aussilhou
Béatrice Aussilhou
FFFadhel Samir Ftériche
Fadhel Samir Ftériche
OFOlivier Farges
Olivier Farges
JBJacques Belghiti
Jacques Belghiti
Over the past two decades, laparoscopic surgery has evolved to become the standard approach for many abdominal procedures. The laparoscopic approach for a cholecystectomy was rapidly adopted around the world in the 1990s and now is the gold standard.1 x 1. Litynski, G.S. Erich Muhe and the rejection of laparoscopic cholecystectomy: (1985): a surgeon ahead of his time. JSLS. 1998; 2: 341–346 PubMed | Google Scholar See all References Lesser pain, better cosmetic results, and a shorter hospital stay combined with decreased morbidity and mortality expanded the scope of laparoscopic procedures to hernia repair, splenectomy, adrenalectomy, antireflux surgery and bariatric surgery.2 x 2. Payne, J.H. Jr., Tashima, W., Lapschies, B., Washecka, R., Hariharan, A., and Duh, Q.Y. Advanced laparoscopy: ‘the next generation’. The adrenal, kidney, spleen, pancreas, and liver. Hawaii Med J. 1998; 57: 710–714 PubMed | Google Scholar See all References Although the first laparoscopic liver resection was described by Reich et al. in 1991,3 x 3. Reich, H., McGlynn, F., DeCaprio, J., and Budin, R. Laparoscopic excision of benign liver lesions. Obstet Gynecol. 1991; 78: 956–958 PubMed | Google Scholar See all References the evolution of the laparoscopic liver resection has been considerably restricted. This may reflect the lack of expertise owing to the higher level of complexity involved in laparoscopic liver procedures or the limited dissemination of advanced laparoscopic techniques among a majority of liver surgeons.4 x 4. Buell, J.F., Cherqui, D., Geller, D.A., O'Rourke, N., Iannitti, D., Dagher, I. et al. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg. 2009; 250: 825–830 Crossref | PubMed | Scopus (620) | Google Scholar See all References Of the procedures of liver resection, the left lateral segment of the liver is seen as the first choice for a laparoscopic anatomic resection because of its peripheral location, the thin parenchyma along the ligamentum venosum groove, the minimal requirement for hilar biliary dissection and easy control of the left hepatic vein with a vascular stapler. This case–control study evaluates a left lateral sectionectomy for benign liver tumours.

31 December 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
SLSanne Lof
Sanne Lof
FVF L Vissers
F L Vissers
SKS Klompmaker
S Klompmaker
SBS Berti
S Berti
UBU Boggi
U Boggi
T(the European consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)
the European consortium on Minimally Invasive Pancreatic Surgery (E-MIPS)
Minimally invasive pancreatoduodenectomy (MIPD) is increasingly being performed because of perceived patient benefits. Whether conversion of MIPD to open pancreatoduodenectomy worsens outcome, and which risk factors are associated with conversion, is unclear. This was a post hoc analysis of a European multicentre retrospective cohort study of patients undergoing MIPD (2012–2017) in ten medium-volume (10–19 MIPDs annually) and four high-volume (at least 20 MIPDs annually) centres. Propensity score matching (1 : 1) was used to compare outcomes of converted and non-converted MIPD procedures. Multivariable logistic regression analysis was performed to identify risk factors for conversion, with results presented as odds ratios (ORs) with 95 per cent confidence intervals (c.i). Overall, 65 of 709 MIPDs were converted (9.2 per cent) and the overall 30-day mortality rate was 3.8 per cent. Risk factors for conversion were tumour size larger than 40 mm (OR 2.7, 95 per cent c.i.1.0 to 6.8; P = 0.041), pancreatobiliary tumours (OR 2.2, 1.0 to 4.8; P = 0.039), age at least 75 years (OR 2.0, 1.0 to 4.1; P = 0.043), and laparoscopic pancreatoduodenectomy (OR 5.2, 2.5 to 10.7; P < 0.001). Medium-volume centres had a higher risk of conversion than high-volume centres (15.2 versus 4.1 per cent, P < 0.001; OR 4.1, 2.3 to 7.4, P < 0.001). After propensity score matching (56 converted MIPDs and 56 completed MIPDs) including risk factors, rates of complications with a Clavien–Dindo grade of III or higher (32 versus 34 per cent; P = 0.841) and 30-day mortality (12 versus 6 per cent; P = 0.274) did not differ between converted and non-converted MIPDs. Risk factors for conversion during MIPD include age, large tumour size, tumour location, laparoscopic approach, and surgery in medium-volume centres. Although conversion during MIPD itself was not associated with worse outcomes, the outcome in these patients was poor in general which should be taken into account during patient selection for MIPD.